UF College of Pharmacy graduate students Amy Alleyne and Corey Perkins earned second place awards in the UF Graduate Student Diversity Research Day poster contest, April 6.
GLP-1 plays an important role in regulating appetite by creating the sensation of feeling full after a meal. UF's findings could have far-reaching implications for developing new medicines designed to treat obesity.
An anticancer drug developed by researchers from the University of Florida College of Pharmacy has become the first drug of its kind allowed to proceed to clinical trial by the U.S. Food and Drug Administration.
UF pharmacy researchers have found a potential new way of targeting a population of immune-suppressive T cells that could possibly benefit a large population of cancer patients, including those who will not respond to other immunotherapies.
The study led by Siobhan Malany, Ph.D., will help scientists understand microgravity effects on human muscle cells and could aid the development of new therapies for age-related muscle loss on Earth.
The University of Florida College of Pharmacy awarded the three prestigious fellowships at a virtual award ceremony Oct. 13.
The incoming class features 21 Ph.D. and two residential master’s students, from nine states and four countries.
When it became evident in late March that most research would be halted because of COVID-19, Dr. Jay McLaughlin’s lab went into high gear.
Graduate students Ariana Brice-Tutt and Mohammed Gbadamosi received AFPE Pre-Doctoral Research Fellowships, while Razanne Oueini, a Pharm.D. student, received a Gateway to Research Fellowship award.
The faculty were recognized for their contributions to the University of Florida, their profession and society.